Skip to main content
Erschienen in: Pediatric Radiology 10/2020

Open Access 28.05.2020 | Review

Imaging of complications following Fontan circulation in children — diagnosis and surveillance

verfasst von: Charlotte de Lange

Erschienen in: Pediatric Radiology | Ausgabe 10/2020

Abstract

The Fontan operation is performed for various cardiac lesions with single-ventricle physiology. The survival rate of Fontan patients is increasing for adolescents and young adults, with an expected 30-year survival of >80%. Medical health care providers including specialists in organ systems and pediatric radiologists need to improve their knowledge about the Fontan circulation and the various organ complications to monitor care. In this review the author explains the basic anatomical and functional features of Fontan palliation and gives an overview of the multiple long-term organ complications that might present in the pediatric population. These include decreased physical capacity, ventricular dysfunction, atrioventricular valve regurgitation and arrhythmia, as well as protein-losing enteropathy, plastic bronchitis, growth/bone composition disturbances, renal dysfunction, and the recently recognized and important liver fibrosis (Fontan-associated liver disease). Neuropsychological and behavioral deficits occur frequently. This review focuses on the key role of radiology in making the diagnosis of these complications, monitoring therapy and predicting outcomes in the pediatric age group. The author discusses how and when radiology is important in Fontan patients, as well as how new techniques enabling quantitative measures in imaging with US, MRI and CT are adapted for pediatric use, and how they contribute to urgently needed surveillance strategies.
Begleitmaterial
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00247-020-04682-5) contains supplementary material, which is available to authorized users.
A correction to this article is available online at https://​doi.​org/​10.​1007/​s00247-020-04787-x.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Four decades after the first operation performed by Francis Fontan, much is still unknown of the pathophysiological mechanisms and complications of Fontan palliation as a lifesaving treatment for single-ventricle congenital heart disease. The ventricular function alone is not predictive for a Fontan patient’s quality of life and the multiple types of problems can interact to give the unique features of complications in this equally exclusive and growing population. These children require lifelong follow-up with medical care, implicating an important financial and societal impact.
The Fontan operation creates an artificial circulation with two serial capillary beds by connecting the superior and inferior caval veins to the pulmonary arteries (Fig. 1) [1]. In the final Fontan circulation, transpulmonary blood flow is driven by a moderately elevated central venous pressure high enough to overcome the pulmonary vascular resistance (Fig. 2) [2]. The most important elements of Fontan circulation include:
  • reduced cardiac output,
  • increased central venous pressure and
  • non-pulsatile hepatic congestion and fibrosis/cirrhosis.
These features have an impact on both visceral organs and lymphatic drainage, causing important complications (Fig. 3) [25]. One of the most important effects that is lately gaining more awareness is Fontan-associated liver disease with development of fibrosis/cirrhosis and risk for malignant transformation. Liver disease is of major concern in young adult Fontan patients, whereas the prevalence and impact in the pediatric population is less well explored [68].
The cardiac complications with decreased cardiac output go along with decreased physical capacity, ventricular dysfunction, atrioventricular valve regurgitation and arrhythmia. The veno-lymphatic congestion with protein-losing enteropathy and plastic bronchitis are a considerable problem for some patients, as well as renal dysfunction, growth disturbances and bone composition abnormalities that can progress over time. Neurodevelopmental disorders and psychological problems are highly prevalent.
Imaging is gaining an important role in the follow-up of this patient group and, most important, in the evaluation of cardiac, lymphatic and liver function. Cardiac and thoracic CT and cardiac MRI are used to supplement or replace echocardiography and cardiac catheterization for assessing the cardiac status. In addition, with the increasing awareness of other end-organ injuries, new techniques in US, CT and MRI such as elastography, relaxometry with quantitative measures, and lymphatic imaging with image-guided interventions have become increasingly important.
The question is whether and how these children should be followed appropriately to identify treatable complications. One study suggests that with a growing adult population with congenital heart disease, adult congenital cardiologists should assure the transition from pediatric to adult care actively and start this process during early adolescence, continuing until successful engagement [9].
The involvement of multiple organs in Fontan circulation is challenging to manage and requires a multidisciplinary approach by those with medical knowledge of the pathophysiological origin to achieve optimal care for this distinct condition. This includes clinicians from many pediatric and adult specialties, including hepatology, pneumology, endocrinology, cardiology and radiology.

Incidence, prognosis and outcome

Up to 70,000 people with Fontan-type palliation might be alive worldwide, and the population is expected to double the next 20 years [5, 10, 11]. The long-term survival is increasing because of surgical refinements and improved pre-, peri- and postoperative care, but this varies among countries. Today, 20-year survival estimates are 61–85% [2, 1114]. Known factors negatively influencing outcomes are multiple, such as having a single right ventricle, male gender, common atrioventricular valve, older age at Fontan operation, postoperative complications with increased pulmonary pressures, and prolonged pleural effusions after Fontan completion [3]. Likewise, protein-losing enteropathy, arrhythmia and thromboembolic events are associated with shorter survival.
The Fontan circulation is a palliation, and cardiac transplantation — the only curable treatment for a failing Fontan circulation — has important implications for survival. The paediatric heart network reported 15-year survival results ranging from 0% to 21% across centers among those who received a cardiac transplant after Fontan surgery completion [15].

Pathophysiology

The most common type of heart defect treated with a Fontan operation is hypoplastic left heart syndrome. However, in several other defects with a single functional ventricle such as tricuspid atresia, double-outlet right ventricle, some types of pulmonary atresia, and atrioventricular septum defects, the only treatment option might be the Fontan palliation. In many cases, either the left or the right ventricle is dominant, serving as the systemic ventricle (Fig. 4).
The goal with a Fontan palliation is to create a serial circulation where the systemic venous return via the superior and inferior caval veins reach the pulmonary vascular bed without the pumping pressure of the right ventricle. Instead, systemic venous blood return is driven by increased central venous pressure and without pulsations (Fig. 1).
This passive blood flow does, however, limit the ventricular volume load and thereby limit the possibility of increasing cardiac output during physical activity (Fig. 2). The non-pulsatile flow additionally causes injury of pulmonary vessel walls with elevated pulmonary vascular resistance. Combined with limited capacity of ventricular filling, this leads to a circulatory failure, but not necessarily combined with a failing ventricular pump function [4]. As a compensation, venovenous, aortopulmonary and even pulmonary arteriovenous collaterals develop at the cost of desaturation and cardiac volume overload.

Surgical treatment

The surgical repair is generally performed in planned stages (Fig. 5). The first operation is carried out when necessary shortly after birth to assure sufficient arterial flow and oxygenation to the lungs and body. This operation might differ depending on the type of defect, but in hypoplastic left heart syndrome, a Blalock–Taussig shunt or a central aorto-pulmonary shunt is placed and one common atrium created by a large interatrial defect to secure free return of pulmonary and systemic venous flow (Fig. 5). The following stage of transitional superior cavo-pulmonary connection (either a bidirectional Glenn or cavo-pulmonary connection) is performed at about 6 to 8 months of age. The operation for the final stage, a total cavo-pulmonary connection, is accomplished in most centers when the child weighs about 15 kg, at 2–4 years of age (Fig. 5) [16].
Historically, three main surgical techniques for the final Fontan stage have been used and continuously refined over the years. The initial type was introduced by Francis Fontan in 1971 and was further refined by Guillermo Kreutzer in 1973 using the “atriopulmonary connection,” where the right atrial appendage connects to the left pulmonary artery [1, 17]. In the second, “the lateral tunnel approach,” a tunnel inside the atrium creates a connection to the pulmonary artery to achieve a total cavo-pulmonary connection.
Most children today undergo a third technique, using an extracardiac conduit in Gore-Tex placed lateral to the right of the common atrium between the inferior caval vein and the left pulmonary artery (Fig. 5 and supplementary material) [18]. Some centers perform a fenestration between the conduit and the common atrium to temporarily reduce the central venous pressure, i.e. a controlled right-to-left shunt, at the cost of increased cyanosis. This seems to decrease the amount of immediate postoperative pleural effusion, and the fenestration might eventually close naturally or be closed later [19].

Complications of Fontan circulation and the role of imaging

The Fontan circulation is a life-saving procedure providing many children an acceptable quality of life for several years [20]. However, long-term complications occur, and with increasing severity from adolescence (Table 1; Fig. 3) [5, 6, 2125]. In single-ventricle physiology, the hemodynamic situation is abnormal already in fetal life, with deprived oxygenation that is detrimental to body organs and further develops after Fontan completion (Table 1; Fig. 3) [24]. Ultimately, this can lead to a “failing Fontan circulation,” a term traditionally used when several and severe complications are present and can lead to death [26]. It does not necessarily include a circulatory failure caused by ventricular dysfunction, but it can be the result of pulmonary vascular dysfunction, thromboembolism, organ failure or arrhythmia. Most imaging techniques using echocardiography, radiography, US, CT, MRI and conventional angiography are applicable for investigating the complications in the heart and in secondary findings in the thorax and end organs.
Table 1
Long-term complications of Fontan circulation and the appropriate imaging techniques to investigate and monitor them
Organ system
Complication
Radiologic investigation, monitoring
General
Reduced physical capacity (present in 100% of patients)
 
Cardiac
Ventricular dysfunction
Echocardiography/cardiac MRI/CT
Atrioventricular valve regurgitation
Arrhythmia
Heart failure
Cyanosis
Lungs
Increased pulmonary vascular resistance
CT/catheterization
Angiography/cardiac MRI
Aortopulmonary/venovenous collaterals
Liver
Fibrosis/cirrhosis/hepatocellular carcinoma
US, CT, MRI
Kidney
Renal dysfunction
Doppler US
Veno-lymphatic system
Lymphangiectasia
MR, lymphangiography
Plastic bronchitis
MR/CT/lymphangiography
Protein-losing enteropathy
Catheterization intervention
Bone
Growth disturbances
Radiographic bone age estimation
Bone mineral deficiency
Bone mineral density measurement
Brain
Neurodevelopmental disorders
MR brain
Cognitive disorders
Behavioral deficits
CT computed tomography, MRI magnetic resonance imaging, US ultrasonography

Cardiovascular complications

Heart failure and ventricular dysfunction

There are two types of heart failure in Fontan patients. They present as the classic ventricular pump failure and the Fontan circulatory failure. The latter relates to the chronic increased central venous pressure and low cardiac output but with a remaining acceptable ventricular function. The systolic and diastolic ventricular function are relatively preserved the first decades after Fontan completion but decline over time [15]. Systolic dysfunction is present in 40–60% of patients considered for heart transplantation [27]. The function might be improved if treatment is possible for coexisting complications such as atrioventricular valve regurgitation, arrhythmia, venovenous and arteriovenous collaterals, and vascular obstructions like stenosis (Fig. 6). Reliable quantification of the function is difficult in single-ventricle physiology because of the complex diverse anatomy and lack of normal reference values and functional indexes for a non-left ventricular systemic ventricle [28].

Atrioventricular valve regurgitation

Historically, significant atrioventricular valve regurgitation was a contraindication for the final Fontan operation, but today medication and options to replace or repair the valve are possible. However, it is still an important complication with often insidious development that can lead to volume overload, ventricular dilation and dysfunction. This can compromise the Fontan circulation, especially in a tricuspid valve serving as a systemic valve [29]. Preoperative evaluation and quantification of ventricular function and valve regurgitation are important to decide the optimal surgical approach and time point [30, 31].

Arrhythmias

Both the anatomy of the single-ventricle congenital heart defect and the type of surgery performed pose a risk for arrhythmia, which occurs in about 41% of Fontan patients [32]. Arrhythmias are associated with increased mortality, morbidity and atrial/ventricular arrhythmia focus (90/10%) [32]. Sinus node dysfunction is predominant in children with extracardiac conduit. Treatment options include antiarrhythmic medication and catheter-based ablation, different modes of pacing or, in specific cases, an implantable cardioverter defibrillator.

Thromboembolic events

Fontan patients have increased risk of developing thrombosis and bleeding. The chronic low oxygen saturation in Fontan patients, about 90–95% at rest, leads to increased hemoglobin and blood viscosity. Together with venous stasis, a low cardiac output and indwelling central lines lead to a hypercoagulable state. On the other hand, intrinsic alterations in thrombophilia factors increase the risk for bleeding. There is no consensus on the use of thromboprophylaxis, which leaves up to one-third of patients at risk of a thromboembolic event. Pulmonary embolism is one of the major mortalities in Fontan patients (Fig. 7) [33].

Imaging in cardiovascular complications

Two-dimensional (2-D) echocardiography is the easiest and first choice of investigation for functional and anatomical examination, with new techniques enabling volumetric measurements, 3-D and 4-D imaging, myocardial strain analysis, and feature tracking [34]. However, interpretation is partly subjective and often hampered, especially for the right ventricle, by limited cardiac views related to patient habitus and postoperative conditions.
Cardiac MRI is the standard for reliable serial evaluation of ventricular performance, valve function and flow data, with the added possibility of an anatomical overview with multiplanar and volume-rendered reconstructions (Fig. 6). Contrast media based on gadolinium or ferumoxytol can enhance the morphology, enabling 3-D print models of the heart defect [35, 36]. Functional flow data can be provided by 2-D phase-contrast sequences, while newer quantitative MR techniques like 4-D flow with computational fluid dynamics are under research and in clinical use in a few institutions and require specific software analysis tools (Fig. 8) [3739]. MR strain analysis and feature tracking are, like echocardiography, newer techniques that are garnering more attention to how diastolic and systolic function perform in the single-ventricle circulation and also in pediatric patients [28, 34].
Magnetic resonance imaging offers the possibility for tissue characterization by relaxometry with T1, T2 and T2* mapping of the myocardium for evaluating evidence of myocardial edema, scarring, diffuse fibrosis and iron deposition [40, 41]. In addition, visualization of the lymphatic system in the thorax with MR lymphography can be employed with and without intravenous contrast agent (Fig. 9) [42]. Many of the new quantitative techniques in MR have only been used in smaller studies in pediatrics and are still under research to provide evidence-based data to prove their usefulness.
Cardiac CT angiography is especially important for coronary artery visualization and in children with MR-incompatible devices or who are not clinically able to undergo a cardiac MRI (Fig. 6). Especially in pediatrics, scanning protocols with radiation-reducing techniques must be used. For Fontan circulation, specific contrast-injection protocols are necessary depending on the clinical question. Knowledge of pitfalls in the interpretation is important [33, 43] (Fig. 7). Functional cardiac information can also be provided by electrocardiography-gated scanning of the whole cardiac cycle at the cost of increased radiation and performed in select cases, such as children with an implantable device like a cardioverter defibrillator [33, 44]. Both MR and CT are used to guide intervention for catheter-based ablation of arrhythmia [45, 46].
Cardiac catheterization provides, invasively, a direct hemodynamic evaluation and the possibility for interventional procedures to relieve and optimize central venous pressure in pulmonary artery stenosis and to treat venovenous or arteriovenous collaterals (Fig. 6). Evaluation before the final Fontan stage of anatomical and functional features is often performed using echocardiography and catheterization in combination. However, many centers prefer cardiac MRI because it is noninvasive, without ionizing radiation, and it provides additional important morphological information and more reliable volumetric measurements than echocardiography [4749].

Fontan-associated liver disease

Fontan-associated liver disease is an inevitable development after Fontan palliation and is a growing concern for these young patients. Although liver injury caused by cardiac dysfunction has long been recognized [50], in Fontan patients, the chronic elevated central venous pressure without pulsations, lymphatic overflow and hypoxia-induced sinusoidal stress results in fibrosis/cirrhosis with special features where the pathophysiological mechanisms are still not fully understood. Fibrosis can be seen in the first 5 years after Fontan completion [6, 51] and develops in different phases during adolescence/adulthood to end-stage chronic liver disease, where most complications occur, such as portal hypertension with variceal bleeding, ascites, hepatic encephalopathy and hepatocellular carcinoma [6, 8, 23]. Typically, hepatic serological markers are normal or only slightly deranged, with increase in transaminases, glutamyl transferase and bilirubin and with no or few clinical findings until the more advanced stages or development of hepatocellular carcinoma, where serum alpha-fetoprotein might be increased [52]. The venous hypertension mimics a hepatic venous outlet obstruction and gives rise to arterialization of hepatic blood flow with presence of hypervascular nodules [53]. Other types of nodules develop with or without signs of cirrhosis, with hepatocellular carcinoma reported in 1.3% of Fontan patients as young as 12 years [23, 54].
The American College of Cardiology statement on Fontan-associated liver disease and several other reports and researchers advocate for periodic radiologic liver assessment screening and longitudinal follow-up of fibrosis. In addition, there is a need for a workup and a surveillance plan for malignant transformation in the presence of larger nodules [6, 52, 55]. Monitoring liver disease development is important for medical and interventional treatment to optimize the Fontan circulation and to identify the optimal time point for cardiac transplantation [56].
Ultrasonography has been proposed as a first choice of investigation, although it is relatively insensitive in detecting fibrotic changes and can miss nodules, which are often isoechoic with the liver parenchyma [57]. US imaging can, however, identify early phases of congestive hepatopathy and provide hemodynamic information on hepatic flow, important for serial evaluation of fibrosis/cirrhosis development. US elastography, especially shear-wave techniques, is gaining more experience in the serial follow-up in these patients [57, 58]. Increased liver stiffness is present in the immediate Fontan postoperative period and persists in the majority of patients (Fig. 10) [59]. Nonetheless, elastography results must be interpreted with caution in the Fontan population because, unlike in other forms of chronic liver disease, no validated cut-offs of severe liver fibrosis are available, especially in pediatrics [55, 60].
Use of contrast-enhanced US imaging in the liver in Fontan patients has not been reported. Although the second-generation US contrast agents like SonoVue (Bracco, Milan, Italy) are approved for pediatric use to diagnose liver lesions in the United States, off-label use in Europe needs careful consideration. Low frequency of adverse effects is reported but the fact that many Fontan patients have serious cardiac dysfunction and venovenous shunting via collaterals could be a contraindication for use [61, 62].
Computed tomography and MRI provide more detailed and accurate complementary information on structure and morphology of the liver tissue and characterization of the liver nodules in different vascular phases, and for MRI, hepatocyte-specific contrast agents can also be used (Figs. 6, 10 and 11). The liver congestion makes the interpretation of nodular vascular enhancement difficult. For diagnosis of hepatocellular carcinoma, the imaging criteria proposed in the Liver Imaging Reporting and Data System (LIRADS) are less reliable [55, 63]. Therefore, contrary to recommendations in adults with nodules suspicious for malignancy, biopsy is suggested in Fontan patients to verify the diagnosis [7, 55]. The role of liver biopsy as routine in the staging of fibrosis/cirrhosis is under debate. Although considered the gold standard in diagnosing cirrhosis, it is an expensive, invasive procedure with risks of complications and sampling errors because of the heterogeneous distribution in this type of liver disease [7, 52, 64, 65].
Other techniques including diffusion-weighted imaging, MR elastography, and relaxometry with T1, T2 and T1rho mapping have been reported to be useful in the diagnosis and in assessing the central venous pressure (Fig.10) [6668]. US/MRI shear-wave elastography cannot distinguish hepatic congestion from fibrosis but the composite of these two measures might be of important clinical value in the longitudinal follow-up of Fontan-associated liver disease [55, 58].
The cardiac Fontan surgery leads to acute kidney injury. In addition, the kidneys are susceptible to decreased cardiac output as well as possible nephrotoxic medication, cardiopulmonary bypass runs (inflammation), intravenous iodinated contrast agents and longstanding cyanosis. This Fontan-related renal dysfunction often goes undetected until adolescence and adulthood. Measured renal function, i.e. glomerular filtration as opposed to estimated glomerular filtration, is abnormal in at least 10% of these children, with increasing prevalence in adolescents and adults [5].
Monitoring renal function using US Doppler resistive index is of growing interest as a marker of heart failure and end organ damage in adult congenital heart disease. A recent pediatric Fontan study revealed that a high index >0.81 reflects the severity of heart failure, hepatic and renal function, glucose intolerance and overall mortality [69].

Veno-lymphatic complications

Both protein-losing enteropathy and plastic bronchitis represent the clinical manifestation of chronic venous congestion induced by lymphatic insufficiency and abnormal lymphatic channels [70]. Protein-losing enteropathy affects 3–18% of Fontan patients and is a life-threatening disease when proteins leak into the small bowel [22, 60]. The pathophysiological mechanisms of protein-losing enteropathy in Fontan circulation are incompletely understood and seem to differ compared to other forms. In a recent study by Rodriguez et al. [60], protein-losing enteropathy seemed to be associated with advanced liver disease and markers of inflammation and intestinal permeability. Protein-losing enteropathy diagnosis is made by the evidence of elevated fecal α1-antitrypsin in combination with serum hypoalbuminemia and clinical edemas.
Plastic bronchitis is reported to occur in <5% of individuals with Fontan circulation and consists of thick tenacious casts of lymphatic protein-rich fluid from broncho-lymphatic communications, produced within the bronchial tree. Plastic bronchitis is diagnosed after detection of these casts by patient expectoration or by bronchoscopic removal. The casts can partially or completely obstruct the airway, leading to severe hypoxemia and asphyxiation.
The relationship between lymphatic congestion and end organ damage such as liver fibrosis, protein-losing enteropathy and Vitamin D insufficiency and nutrition needs to be further explored. Both plastic bronchitis and protein-losing enteropathy are challenging to treat medically and until recently there was only one option, cardiac transplantation. Nevertheless, recent advances with surgical and interventional procedures have been quite successful, although with a risk of recurrence because these interventions do not treat the Fontan circulation itself and the inherent venous hypertension [71].
Imaging has quite recently gained an important role to investigate and tailor interventional treatment. Using MR lymphography based on heavily T2-weighted sequences, patterns of lymphatic vascular architecture in the chest and abdomen can be delineated (Fig. 9). When performed in conjunction to the Fontan completion, these patterns have been shown to predict the outcome with high association to protein-losing enteropathy and plastic bronchitis [72]. New treatment options, including surgical and catheter-based intervention to occlude or stent vasculo-lymphatic or bronco-lymphatic pathways, have been successful in small series with good outcomes as well as low morbidity and mortality [42, 73]. Lymphatic conventional angiography and intervention might also be an option in tertiary and specific centers, even with intrahepatic MR lymphography reported [71].

Bone health and growth

Fontan patients have impaired growth with lower stature compared to the normal population.
Decreased Vitamin D levels and increased parathyroid hormone, low lean muscle mass and decreased cortical bone mineral density are key findings in this patient group [5]. In a recent study, bone mineral density levels decreased with age in people with Fontan circulation where different bone components were involved. Vitamin D levels also decreased with age, but this was not consistently associated with bone mineral density [74]. The reason for the decrease of Vitamin D in Fontan patients is unknown but is thought to be related to altered gut circulation and Vitamin D absorption.
Radiographic bone age estimation, especially using automated techniques in addition to bone mineral density measurements like dual-energy X-ray absorptiometry, can be performed to guide treatment. Dual-energy X-ray absorptiometry is of limited value in pediatrics because of the lack of pediatric normal reference values of bone mineral density in the younger age group [75].

Central nervous system and neurocognitive function

There is increasing awareness of neurologic, neurodevelopmental and behavioral abnormalities in congenital heart disease, and especially in Fontan patients. The potential causes of brain injury in congenital heart disease are cumulative and interactive. There are genetic causes, with in utero disturbed hemodynamics that can reduce oxygen delivery and cerebral maturation. Other factors are patient-related, like low birth weight and preterm birth. The different steps of surgical treatment and cardiac catheterization contribute to the risk of hypoxic–ischemic injury and embolic events [25]. Neurocognitive impairment impedes academic achievement and evaluation in early school years. There is a need to target patients who might benefit from interventions. Improving the understanding of how to manage cognitive and psychiatric outcomes in adult congenital heart disease, especially Fontan patients, is a prioritized area of research.
Fetal and neonatal MR studies in children with a single ventricle have shown abnormalities in maturation, volumetric growth and white matter already in fetal life [7679]. MR findings in later life show striking deviations from normal in most people, with focal and multifocal abnormalities of different degrees. Findings show that non-acute ischemic changes such as atrophy and ventriculomegaly accumulate with staged surgical reconstruction [80]. Typically, spreading white matter abnormalities have been associated with cognitive impairment as well as gray matter abnormalities [81, 82].

Heart transplantation

The only curable treatment for children with Fontan circulation is a heart transplantation. There is an ongoing debate on the optimal time point to perform a transplantation. Many children reach such a serious reduced clinical state before considering transplantation that the procedure itself becomes too dangerous regarding pre-, peri- and postoperative complications [83]. Ventricular assist devices might be necessary to bridge a cardiac transplantation in trying to achieve a better clinical and functional state [84]. Advanced liver cirrhosis and even malignant transformation might prohibit transplantation or require a combined liver and heart transplantation [6]. There has been a high early post-transplantation mortality rate in this patient group, but with better perioperative treatment, survival is increasing and is now comparable to the rate in other types of congenital heart disease undergoing transplantation [85].
Pre- and post-transplantation imaging consists of chest radiography, CT and cardiac MRI to delineate morphological and functional features that are important for the choice of surgical approach and post-transplant complications [86].

Radiologic imaging in the surveillance of Fontan patients

What is the role of imaging in the surveillance of this patient group? No or very few evidence-based studies exist because of the still quite short observational period, and the proposed published guidelines until now were mainly based on experience in the adult age group. When a pediatric cardiologist follows a Fontan patient, his or her personal knowledge of how the other organs are affected will guide the surveillance by other clinical specialties. When these children reach early adolescence, their transition and follow-up from pediatric to adult care regarding both cardiology and radiology needs to be assured until successful commitment [9].
A statement from the American Heart Association from 2019 acknowledged that there is insufficient evidence base for developing clear recommendations but that cardiac and end-organ surveillance in children and adults is warranted and clinically important [5]. Furthermore, the statement said that monitoring should be performed by multidisciplinary Fontan/single-ventricle care clinics with health care personnel familiar with and experienced with Fontan circulation and complications [5]. It is expected that a surveillance protocol — the frequency and type of tests, including imaging — will, with the increased knowledge and experience from multicenter studies, be transformed in the future. Cardiac and end-organ imaging has an important part as a supplement to clinical assessment and other tests and should be carried out at defined intervals as proposed [5] and as discussed in this section.
Cardiovascular imaging assessment is already common at many institutions and should be performed in all age groups at set intervals. Cardiac MR with anatomical and functional investigation should be performed every 2–3 years and CT angiography when clinically indicated [47]. Cardiac catheterization is recommended once every 10 years or when clinically indicated [28].
End-organ status assessment is a newer concept where imaging and frequency should be tailored to patient age — every 3–4 years for children ages <12 years and every 1–3 years for adolescents ages 12–18 years. Findings at any test might change the interval for follow-up or initiate other investigations. The general imaging strategy should be as follows:
  • Lymphatic and endocrine system: MR lymphography with T2-weighted MR imaging as a new technique is recommended as likely to be of value as a part of a cardiac MR examination. Bone-age estimation and bone-mineral-density assessment are also recommended.
  • Brain and neurocognitive function: In addition to neurodevelopmental/cognitive testing, a brain MR examination can provide important information.
  • Lungs: Chest radiography is recommended.
  • Liver: Abdominal/liver US is recommended, including elastography if possible. MRI including liver biopsy might be considered. In the adolescent, this becomes even more important, especially monitoring liver disease development, because advanced-stage cirrhosis or even hepatocellular carcinoma might preclude transplantation. Annual US imaging with elastography has been proposed for adolescents ages 15–16 years, with more frequent controls if radiologic signs of fibrosis and nodules are found [52]. Some centers advocate annual liver MR from adolescence on, later combined with US elastography when routine biopsy is proposed [6, 7, 52].
However, the optimal management strategy for the pediatric population remains to be established [54].

Conclusion

Although the Fontan procedure has extended patients’ lifespan, an important risk of morbidity and mortality remains. Children receiving surgical treatment with a Fontan procedure at the time of birth require lifelong follow-up with medical care, implicating an important financial and societal impact. Still, much is unknown of how the Fontan palliation affects patients differently. End-organ effects are increasingly recognized, where mainly the cardiac, lymphatic and liver changes require monitoring with radiologic techniques to ensure the optimal timing for treatment and eventually cardiac transplantation. Increasing knowledge in pediatric radiology is urgently needed regarding this growing patient group and the pathology in end organs in addition to the cardiac changes.

Acknowledgments

Open Access funding provided by University of Oslo (incl Oslo University Hospital). I especially would like to thank Michael Bjaanes for his contribution in creating the figures and animations to illustrate the Fontan circulation.

Compliance with ethical standards

Conflicts of interest

None
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Pädiatrie

Kombi-Abonnement

Mit e.Med Pädiatrie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Pädiatrie, den Premium-Inhalten der pädiatrischen Fachzeitschriften, inklusive einer gedruckten Pädiatrie-Zeitschrift Ihrer Wahl.

e.Med Radiologie

Kombi-Abonnement

Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.

Anhänge

Electronic supplementary material

Literatur
2.
Zurück zum Zitat Diab SG, Dohlen G, Seem E, Moller T (2019) [Fontan circulation with univentricular heart disease]. Tidsskr Nor Laegeforen 11:139 Diab SG, Dohlen G, Seem E, Moller T (2019) [Fontan circulation with univentricular heart disease]. Tidsskr Nor Laegeforen 11:139
3.
Zurück zum Zitat Rychik J (2010) Forty years of the Fontan operation: a failed strategy. Semin Thorac Cardiovasc Surg Pediatr Cardiac Surg Annu 13:96–100CrossRef Rychik J (2010) Forty years of the Fontan operation: a failed strategy. Semin Thorac Cardiovasc Surg Pediatr Cardiac Surg Annu 13:96–100CrossRef
4.
Zurück zum Zitat Mori M, Aguirre AJ, Elder RW et al (2014) Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol 35:569–579PubMedCrossRef Mori M, Aguirre AJ, Elder RW et al (2014) Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol 35:569–579PubMedCrossRef
6.
Zurück zum Zitat Daniels CJ, Bradley EA, Landzberg MJ et al (2017) Fontan-associated liver disease: proceedings from the American College of Cardiology stakeholders meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol 70:3173–3194PubMedCrossRef Daniels CJ, Bradley EA, Landzberg MJ et al (2017) Fontan-associated liver disease: proceedings from the American College of Cardiology stakeholders meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol 70:3173–3194PubMedCrossRef
7.
Zurück zum Zitat Munsterman ID, Duijnhouwer AL, Kendall TJ et al (2019) The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort. Eur Heart J 40:1057–1068PubMedCrossRef Munsterman ID, Duijnhouwer AL, Kendall TJ et al (2019) The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort. Eur Heart J 40:1057–1068PubMedCrossRef
8.
Zurück zum Zitat Tellez L, Rodriguez de Santiago E, Albillos A (2018) Fontan-associated liver disease. Rev Esp Cardiol (Engl Ed) 71:192–202CrossRef Tellez L, Rodriguez de Santiago E, Albillos A (2018) Fontan-associated liver disease. Rev Esp Cardiol (Engl Ed) 71:192–202CrossRef
9.
Zurück zum Zitat Zentner D, Celermajer DS, Gentles T et al (2020) Management of people with a Fontan circulation: a Cardiac Society of Australia and New Zealand position statement. Heart Lung Circ 29:5–39PubMedCrossRef Zentner D, Celermajer DS, Gentles T et al (2020) Management of people with a Fontan circulation: a Cardiac Society of Australia and New Zealand position statement. Heart Lung Circ 29:5–39PubMedCrossRef
10.
Zurück zum Zitat Schilling C, Dalziel K, Nunn R et al (2016) The Fontan epidemic: population projections from the Australia and New Zealand Fontan registry. Int J Cardiol 219:14–19CrossRefPubMed Schilling C, Dalziel K, Nunn R et al (2016) The Fontan epidemic: population projections from the Australia and New Zealand Fontan registry. Int J Cardiol 219:14–19CrossRefPubMed
11.
Zurück zum Zitat Downing TE, Allen KY, Glatz AC et al (2017) Long-term survival after the Fontan operation: twenty years of experience at a single center. J Thorac Cardiovasc Surg 154:243–253CrossRefPubMed Downing TE, Allen KY, Glatz AC et al (2017) Long-term survival after the Fontan operation: twenty years of experience at a single center. J Thorac Cardiovasc Surg 154:243–253CrossRefPubMed
12.
Zurück zum Zitat Khairy P, Fernandes SM, Mayer JE Jr et al (2008) Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117:85–92CrossRefPubMed Khairy P, Fernandes SM, Mayer JE Jr et al (2008) Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117:85–92CrossRefPubMed
13.
Zurück zum Zitat Kverneland LS, Kramer P, Ovroutski S (2018) Five decades of the Fontan operation: a systematic review of international reports on outcomes after univentricular palliation. Congenit Heart Dis 13:181–193CrossRefPubMed Kverneland LS, Kramer P, Ovroutski S (2018) Five decades of the Fontan operation: a systematic review of international reports on outcomes after univentricular palliation. Congenit Heart Dis 13:181–193CrossRefPubMed
14.
Zurück zum Zitat Erikssen G, Aboulhosn J, Lin J et al (2018) Survival in patients with univentricular hearts: the impact of right versus left ventricular morphology. Open Heart 5:e000902PubMedPubMedCentralCrossRef Erikssen G, Aboulhosn J, Lin J et al (2018) Survival in patients with univentricular hearts: the impact of right versus left ventricular morphology. Open Heart 5:e000902PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Atz AM, Zak V, Mahony L et al (2017) Longitudinal outcomes of patients with single ventricle after the Fontan procedure. J Am Coll Cardiol 69:2735–2744PubMedPubMedCentralCrossRef Atz AM, Zak V, Mahony L et al (2017) Longitudinal outcomes of patients with single ventricle after the Fontan procedure. J Am Coll Cardiol 69:2735–2744PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Bolin EH, Maskatia SA, Tate AL, Petit CJ (2015) Older age at completion of Fontan procedure is associated with improved percentage of predicted maximum oxygen uptake. Tex Heart Inst J 42:333–340PubMedPubMedCentralCrossRef Bolin EH, Maskatia SA, Tate AL, Petit CJ (2015) Older age at completion of Fontan procedure is associated with improved percentage of predicted maximum oxygen uptake. Tex Heart Inst J 42:333–340PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Kreutzer G, Galindez E, Bono H et al (1973) An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg 66:613–621CrossRefPubMed Kreutzer G, Galindez E, Bono H et al (1973) An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg 66:613–621CrossRefPubMed
18.
Zurück zum Zitat de Leval MR, Kilner P, Gewillig M, Bull C (1988) Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 96:682–695CrossRefPubMed de Leval MR, Kilner P, Gewillig M, Bull C (1988) Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 96:682–695CrossRefPubMed
19.
Zurück zum Zitat Lemler MS, Scott WA, Leonard SR et al (2002) Fenestration improves clinical outcome of the Fontan procedure: a prospective, randomized study. Circulation 105:207–212CrossRefPubMed Lemler MS, Scott WA, Leonard SR et al (2002) Fenestration improves clinical outcome of the Fontan procedure: a prospective, randomized study. Circulation 105:207–212CrossRefPubMed
20.
Zurück zum Zitat Muller J, Christov F, Schreiber C et al (2009) Exercise capacity, quality of life, and daily activity in the long-term follow-up of patients with univentricular heart and total cavopulmonary connection. Eur Heart J 30:2915–2920CrossRefPubMed Muller J, Christov F, Schreiber C et al (2009) Exercise capacity, quality of life, and daily activity in the long-term follow-up of patients with univentricular heart and total cavopulmonary connection. Eur Heart J 30:2915–2920CrossRefPubMed
21.
Zurück zum Zitat Rychik J (2016) The relentless effects of the Fontan paradox. Semin Thorac Cardiovasc Surg Pediatr Cardiac Surg Annu 19:37–43CrossRef Rychik J (2016) The relentless effects of the Fontan paradox. Semin Thorac Cardiovasc Surg Pediatr Cardiac Surg Annu 19:37–43CrossRef
22.
Zurück zum Zitat Ostrow AM, Freeze H, Rychik J (2006) Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 82:695–700CrossRefPubMed Ostrow AM, Freeze H, Rychik J (2006) Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 82:695–700CrossRefPubMed
23.
Zurück zum Zitat Egbe AC, Poterucha JT, Warnes CA et al (2018) Hepatocellular carcinoma after Fontan operation. Circulation 138:746–748CrossRefPubMed Egbe AC, Poterucha JT, Warnes CA et al (2018) Hepatocellular carcinoma after Fontan operation. Circulation 138:746–748CrossRefPubMed
24.
Zurück zum Zitat Gewillig MH, Lundstrom UR, Deanfield JE et al (1990) Impact of Fontan operation on left ventricular size and contractility in tricuspid atresia. Circulation 81:118–127CrossRefPubMed Gewillig MH, Lundstrom UR, Deanfield JE et al (1990) Impact of Fontan operation on left ventricular size and contractility in tricuspid atresia. Circulation 81:118–127CrossRefPubMed
25.
Zurück zum Zitat Goldberg CS, Lu M, Sleeper LA et al (2014) Factors associated with neurodevelopment for children with single ventricle lesions. J Pediatr 165:490–496PubMedPubMedCentralCrossRef Goldberg CS, Lu M, Sleeper LA et al (2014) Factors associated with neurodevelopment for children with single ventricle lesions. J Pediatr 165:490–496PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Book WM, Gerardin J, Saraf A et al (2016) Clinical phenotypes of Fontan failure: implications for management. Congen Heart Dis 11:296–308CrossRef Book WM, Gerardin J, Saraf A et al (2016) Clinical phenotypes of Fontan failure: implications for management. Congen Heart Dis 11:296–308CrossRef
27.
Zurück zum Zitat Miller JR, Simpson KE, Epstein DJ et al (2016) Improved survival after heart transplant for failed Fontan patients with preserved ventricular function. J Heart Lung Transplant 35:877–883PubMedPubMedCentralCrossRef Miller JR, Simpson KE, Epstein DJ et al (2016) Improved survival after heart transplant for failed Fontan patients with preserved ventricular function. J Heart Lung Transplant 35:877–883PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Meyer SL, Ridderbos FS, Wolff D et al (2020) Serial cardiovascular magnetic resonance feature tracking indicates early worsening of cardiac function in Fontan patients. Int J Cardiol 303:23–29CrossRefPubMed Meyer SL, Ridderbos FS, Wolff D et al (2020) Serial cardiovascular magnetic resonance feature tracking indicates early worsening of cardiac function in Fontan patients. Int J Cardiol 303:23–29CrossRefPubMed
29.
Zurück zum Zitat Stamm C, Anderson RH, Ho SY (1997) The morphologically tricuspid valve in hypoplastic left heart syndrome. Eur J Cardiothorac Surg 12:587–592CrossRefPubMed Stamm C, Anderson RH, Ho SY (1997) The morphologically tricuspid valve in hypoplastic left heart syndrome. Eur J Cardiothorac Surg 12:587–592CrossRefPubMed
30.
Zurück zum Zitat Honjo O, Mertens L, Van Arsdell GS (2011) Atrioventricular valve repair in patients with single-ventricle physiology: mechanisms, techniques of repair, and clinical outcomes. Semin Thorac Cardiovasc Surg Pediatr Cardiac Surg Annu 14:75–84CrossRef Honjo O, Mertens L, Van Arsdell GS (2011) Atrioventricular valve repair in patients with single-ventricle physiology: mechanisms, techniques of repair, and clinical outcomes. Semin Thorac Cardiovasc Surg Pediatr Cardiac Surg Annu 14:75–84CrossRef
31.
Zurück zum Zitat Kotani Y, Honjo O, Shani K et al (2012) Is indexed preoperative superior vena cava blood flow a risk factor in patients undergoing bidirectional cavopulmonary shunt? Ann Thorac Surg 94:1578–1583PubMedCrossRef Kotani Y, Honjo O, Shani K et al (2012) Is indexed preoperative superior vena cava blood flow a risk factor in patients undergoing bidirectional cavopulmonary shunt? Ann Thorac Surg 94:1578–1583PubMedCrossRef
32.
Zurück zum Zitat Diller GP, Giardini A, Dimopoulos K et al (2010) Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J 31:3073–3083PubMedCrossRef Diller GP, Giardini A, Dimopoulos K et al (2010) Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J 31:3073–3083PubMedCrossRef
33.
Zurück zum Zitat Ghadimi Mahani M, Agarwal PP, Rigsby CK et al (2016) CT for assessment of thrombosis and pulmonary embolism in multiple stages of single-ventricle palliation: challenges and suggested protocols. Radiographics 36:1273–1284PubMedCrossRef Ghadimi Mahani M, Agarwal PP, Rigsby CK et al (2016) CT for assessment of thrombosis and pulmonary embolism in multiple stages of single-ventricle palliation: challenges and suggested protocols. Radiographics 36:1273–1284PubMedCrossRef
34.
Zurück zum Zitat Ghelani SJ, Harrild DM, Gauvreau K et al (2016) Echocardiography and magnetic resonance imaging based strain analysis of functional single ventricles: a study of intra- and inter-modality reproducibility. Int J Cardiovasc Imaging 32:1113–1120PubMedCrossRef Ghelani SJ, Harrild DM, Gauvreau K et al (2016) Echocardiography and magnetic resonance imaging based strain analysis of functional single ventricles: a study of intra- and inter-modality reproducibility. Int J Cardiovasc Imaging 32:1113–1120PubMedCrossRef
35.
Zurück zum Zitat Nguyen KL, Han F, Zhou Z et al (2017) 4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease. J Cardiovasc Magn Reson 19:40PubMedPubMedCentralCrossRef Nguyen KL, Han F, Zhou Z et al (2017) 4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease. J Cardiovasc Magn Reson 19:40PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Valsangiacomo Buechel ER, Grosse-Wortmann L, Fratz S et al (2015) Indications for cardiovascular magnetic resonance in children with congenital and acquired heart disease: an expert consensus paper of the imaging working group of the AEPC and the cardiovascular magnetic resonance section of the EACVI. Eur Heart J Cardiovasc Imaging 16:281–297CrossRefPubMed Valsangiacomo Buechel ER, Grosse-Wortmann L, Fratz S et al (2015) Indications for cardiovascular magnetic resonance in children with congenital and acquired heart disease: an expert consensus paper of the imaging working group of the AEPC and the cardiovascular magnetic resonance section of the EACVI. Eur Heart J Cardiovasc Imaging 16:281–297CrossRefPubMed
37.
Zurück zum Zitat Warmerdam E, Krings GJ, Leiner T, Grotenhuis HB (2020) Three-dimensional and four-dimensional flow assessment in congenital heart disease. Heart 106:421–426CrossRefPubMed Warmerdam E, Krings GJ, Leiner T, Grotenhuis HB (2020) Three-dimensional and four-dimensional flow assessment in congenital heart disease. Heart 106:421–426CrossRefPubMed
38.
Zurück zum Zitat Kamphuis VP, Elbaz MSM, van den Boogaard PJ et al (2019) Stress increases intracardiac 4D flow cardiovascular magnetic resonance-derived energetics and vorticity and relates to VO2max in Fontan patients. J Cardiovasc Magn Reson 21:43PubMedPubMedCentralCrossRef Kamphuis VP, Elbaz MSM, van den Boogaard PJ et al (2019) Stress increases intracardiac 4D flow cardiovascular magnetic resonance-derived energetics and vorticity and relates to VO2max in Fontan patients. J Cardiovasc Magn Reson 21:43PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Azarine A, Garcon P, Stansal A et al (2019) Four-dimensional flow MRI: principles and cardiovascular applications. Radiographics 39:632–648CrossRefPubMed Azarine A, Garcon P, Stansal A et al (2019) Four-dimensional flow MRI: principles and cardiovascular applications. Radiographics 39:632–648CrossRefPubMed
40.
Zurück zum Zitat Kato A, Riesenkampff E, Yim D et al (2017) Pediatric Fontan patients are at risk for myocardial fibrotic remodeling and dysfunction. Int J Cardiol 240:172–177CrossRefPubMed Kato A, Riesenkampff E, Yim D et al (2017) Pediatric Fontan patients are at risk for myocardial fibrotic remodeling and dysfunction. Int J Cardiol 240:172–177CrossRefPubMed
41.
Zurück zum Zitat Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19:75PubMedPubMedCentralCrossRef Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19:75PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Biko DM, DeWitt AG, Pinto EM et al (2019) MRI evaluation of lymphatic abnormalities in the neck and thorax after Fontan surgery: relationship with outcome. Radiology 291:774–780PubMedCrossRef Biko DM, DeWitt AG, Pinto EM et al (2019) MRI evaluation of lymphatic abnormalities in the neck and thorax after Fontan surgery: relationship with outcome. Radiology 291:774–780PubMedCrossRef
44.
Zurück zum Zitat Groves DW, Olivieri LJ, Shanbhag SM et al (2017) Feasibility of low radiation dose retrospectively-gated cardiac CT for functional analysis in adult congenital heart disease. Int J Cardiol 228:180–183CrossRefPubMed Groves DW, Olivieri LJ, Shanbhag SM et al (2017) Feasibility of low radiation dose retrospectively-gated cardiac CT for functional analysis in adult congenital heart disease. Int J Cardiol 228:180–183CrossRefPubMed
45.
Zurück zum Zitat Cazzoli I, Gunturiz-Beltran C, Guarguagli S et al (2020) Catheter ablation for patients with end-stage complex congenital heart disease or cardiomyopathy considered for transplantation: trials and tribulations. Int J Cardiol 301:127–134CrossRefPubMed Cazzoli I, Gunturiz-Beltran C, Guarguagli S et al (2020) Catheter ablation for patients with end-stage complex congenital heart disease or cardiomyopathy considered for transplantation: trials and tribulations. Int J Cardiol 301:127–134CrossRefPubMed
46.
Zurück zum Zitat Moore BM, Anderson R, Nisbet AM et al (2018) Ablation of atrial arrhythmias after the atriopulmonary Fontan procedure: mechanisms of arrhythmia and outcomes. JACC Clin Electrophysiol 4:1338–1346CrossRefPubMed Moore BM, Anderson R, Nisbet AM et al (2018) Ablation of atrial arrhythmias after the atriopulmonary Fontan procedure: mechanisms of arrhythmia and outcomes. JACC Clin Electrophysiol 4:1338–1346CrossRefPubMed
47.
Zurück zum Zitat Margossian R, Schwartz ML, Prakash A et al (2009) Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan cross-sectional study). Am J Cardiol 104:419–428 Margossian R, Schwartz ML, Prakash A et al (2009) Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan cross-sectional study). Am J Cardiol 104:419–428
48.
Zurück zum Zitat Bell A, Rawlins D, Bellsham-Revell H et al (2014) Assessment of right ventricular volumes in hypoplastic left heart syndrome by real-time three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 15:257–266CrossRefPubMed Bell A, Rawlins D, Bellsham-Revell H et al (2014) Assessment of right ventricular volumes in hypoplastic left heart syndrome by real-time three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 15:257–266CrossRefPubMed
49.
Zurück zum Zitat Fogel MA, Pawlowski TW, Whitehead KK et al (2012) Cardiac magnetic resonance and the need for routine cardiac catheterization in single ventricle patients prior to Fontan: a comparison of 3 groups: pre-Fontan CMR versus cath evaluation. J Am Coll Cardiol 60:1094–1102PubMedCrossRef Fogel MA, Pawlowski TW, Whitehead KK et al (2012) Cardiac magnetic resonance and the need for routine cardiac catheterization in single ventricle patients prior to Fontan: a comparison of 3 groups: pre-Fontan CMR versus cath evaluation. J Am Coll Cardiol 60:1094–1102PubMedCrossRef
50.
Zurück zum Zitat Wells ML, Fenstad ER, Poterucha JT et al (2016) Imaging findings of congestive hepatopathy. Radiographics 36:1024–1037CrossRefPubMed Wells ML, Fenstad ER, Poterucha JT et al (2016) Imaging findings of congestive hepatopathy. Radiographics 36:1024–1037CrossRefPubMed
51.
Zurück zum Zitat Agnoletti G, Ferraro G, Bordese R et al (2016) Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy? Int J Cardiol 209:60–65CrossRefPubMed Agnoletti G, Ferraro G, Bordese R et al (2016) Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy? Int J Cardiol 209:60–65CrossRefPubMed
52.
Zurück zum Zitat Hilscher MB, Johnson JN, Cetta F et al (2017) Surveillance for liver complications after the Fontan procedure. Congen Heart Dis 12:124–132CrossRef Hilscher MB, Johnson JN, Cetta F et al (2017) Surveillance for liver complications after the Fontan procedure. Congen Heart Dis 12:124–132CrossRef
53.
Zurück zum Zitat Yoo SJ, Prsa M, Schantz D et al (2014) MR assessment of abdominal circulation in Fontan physiology. Int J Cardiovasc Imaging 30:1065–1072CrossRefPubMed Yoo SJ, Prsa M, Schantz D et al (2014) MR assessment of abdominal circulation in Fontan physiology. Int J Cardiovasc Imaging 30:1065–1072CrossRefPubMed
54.
Zurück zum Zitat Nandwana SB, Olaiya B, Cox K et al (2017) Abdominal imaging surveillance in adult patients after Fontan procedure: risk of chronic liver disease and hepatocellular carcinoma. Curr Probl Diagn Radiol 47:19–22CrossRefPubMed Nandwana SB, Olaiya B, Cox K et al (2017) Abdominal imaging surveillance in adult patients after Fontan procedure: risk of chronic liver disease and hepatocellular carcinoma. Curr Probl Diagn Radiol 47:19–22CrossRefPubMed
55.
Zurück zum Zitat Tellez L, Rodriguez de Santiago E, Minguez B et al (2020) Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: the VALDIG Fonliver prospective cohort. J Hepato 72:702–710CrossRef Tellez L, Rodriguez de Santiago E, Minguez B et al (2020) Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: the VALDIG Fonliver prospective cohort. J Hepato 72:702–710CrossRef
57.
Zurück zum Zitat Horvat N, Rocha MS, Chagas AL et al (2018) Multimodality screening of hepatic nodules in patients with congenital heart disease after Fontan procedure: role of ultrasound, ARFI elastography, CT, and MRI. AJR Am J Roentgenol 211:1212–1220CrossRefPubMed Horvat N, Rocha MS, Chagas AL et al (2018) Multimodality screening of hepatic nodules in patients with congenital heart disease after Fontan procedure: role of ultrasound, ARFI elastography, CT, and MRI. AJR Am J Roentgenol 211:1212–1220CrossRefPubMed
58.
Zurück zum Zitat Melero-Ferrer JL, Osa-Saez A, Buendia-Fuentes F et al (2014) Fontan circulation in adult patients: acoustic radiation force impulse elastography as a useful tool for liver assessment. World J Pediatr Congen Heart Surg 5:365–371CrossRef Melero-Ferrer JL, Osa-Saez A, Buendia-Fuentes F et al (2014) Fontan circulation in adult patients: acoustic radiation force impulse elastography as a useful tool for liver assessment. World J Pediatr Congen Heart Surg 5:365–371CrossRef
59.
Zurück zum Zitat DiPaola FW, Schumacher KR, Goldberg CS et al (2017) Effect of Fontan operation on liver stiffness in children with single ventricle physiology. Eur Radiol 27:2434–2442CrossRefPubMed DiPaola FW, Schumacher KR, Goldberg CS et al (2017) Effect of Fontan operation on liver stiffness in children with single ventricle physiology. Eur Radiol 27:2434–2442CrossRefPubMed
60.
Zurück zum Zitat Rodriguez de Santiago E, Tellez L, Garrido-Lestache Rodriguez-Monte E et al (2020) Fontan protein-losing enteropathy is associated with advanced liver disease and a proinflammatory intestinal and systemic state. Liver Int 40:638–645CrossRefPubMed Rodriguez de Santiago E, Tellez L, Garrido-Lestache Rodriguez-Monte E et al (2020) Fontan protein-losing enteropathy is associated with advanced liver disease and a proinflammatory intestinal and systemic state. Liver Int 40:638–645CrossRefPubMed
61.
Zurück zum Zitat Ntoulia A, Anupindi SA, Darge K, Back SJ (2018) Applications of contrast-enhanced ultrasound in the pediatric abdomen. Abdom Radiol 43:948–959CrossRef Ntoulia A, Anupindi SA, Darge K, Back SJ (2018) Applications of contrast-enhanced ultrasound in the pediatric abdomen. Abdom Radiol 43:948–959CrossRef
62.
Zurück zum Zitat Sidhu PS, Cantisani V, Deganello A et al (2017) Role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med 38:33–43PubMed Sidhu PS, Cantisani V, Deganello A et al (2017) Role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med 38:33–43PubMed
63.
Zurück zum Zitat Cerny M, Chernyak V, Olivie D et al (2018) LI-RADS version 2018 ancillary features at MRI. Radiographics 38:1973–2001CrossRefPubMed Cerny M, Chernyak V, Olivie D et al (2018) LI-RADS version 2018 ancillary features at MRI. Radiographics 38:1973–2001CrossRefPubMed
64.
Zurück zum Zitat Bulut OP, Romero R, Mahle WT et al (2013) Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure. J Pediatr 163:201–206CrossRefPubMed Bulut OP, Romero R, Mahle WT et al (2013) Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure. J Pediatr 163:201–206CrossRefPubMed
65.
Zurück zum Zitat Goldberg DJ, Surrey LF, Glatz AC et al (2017) Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc 6 Goldberg DJ, Surrey LF, Glatz AC et al (2017) Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc 6
66.
Zurück zum Zitat Serai SD, Trout AT, Miethke A et al (2018) Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis. Pediatr Radiol 48:1256–1272CrossRefPubMed Serai SD, Trout AT, Miethke A et al (2018) Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis. Pediatr Radiol 48:1256–1272CrossRefPubMed
67.
Zurück zum Zitat de Lange C, Reichert MJE, Pagano JJ et al (2019) Increased extracellular volume in the liver of pediatric Fontan patients. J Cardiovasc Magn Reson 21:39PubMedPubMedCentralCrossRef de Lange C, Reichert MJE, Pagano JJ et al (2019) Increased extracellular volume in the liver of pediatric Fontan patients. J Cardiovasc Magn Reson 21:39PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Poterucha JT, Johnson JN, Qureshi MY et al (2015) Magnetic resonance elastography: a novel technique for the detection of hepatic fibrosis and hepatocellular carcinoma after the Fontan operation. Mayo Clin Proc 90:882–894PubMedCrossRef Poterucha JT, Johnson JN, Qureshi MY et al (2015) Magnetic resonance elastography: a novel technique for the detection of hepatic fibrosis and hepatocellular carcinoma after the Fontan operation. Mayo Clin Proc 90:882–894PubMedCrossRef
69.
Zurück zum Zitat Ohuchi H, Negishi J, Hayama Y et al (2017) Renal resistive index reflects Fontan pathophysiology and predicts mortality. Heart 103:1631–1637CrossRefPubMed Ohuchi H, Negishi J, Hayama Y et al (2017) Renal resistive index reflects Fontan pathophysiology and predicts mortality. Heart 103:1631–1637CrossRefPubMed
70.
Zurück zum Zitat Rychik J, Dodds KM, Goldberg D et al (2020) Protein losing enteropathy after Fontan operation: glimpses of clarity through the lifting fog. World J Pediatr Congenit Heart Surg 11:92–96PubMedCrossRef Rychik J, Dodds KM, Goldberg D et al (2020) Protein losing enteropathy after Fontan operation: glimpses of clarity through the lifting fog. World J Pediatr Congenit Heart Surg 11:92–96PubMedCrossRef
71.
Zurück zum Zitat Itkin M, Nadolski GJ (2018) Modern techniques of lymphangiography and interventions: current status and future development. Cardiovasc Intervent Radiol 41:366–376PubMedCrossRef Itkin M, Nadolski GJ (2018) Modern techniques of lymphangiography and interventions: current status and future development. Cardiovasc Intervent Radiol 41:366–376PubMedCrossRef
72.
73.
Zurück zum Zitat Itkin MG, McCormack FX, Dori Y (2016) Diagnosis and treatment of lymphatic plastic bronchitis in adults using advanced lymphatic imaging and percutaneous embolization. Ann Am Thorac Soc 13:1689–1696PubMed Itkin MG, McCormack FX, Dori Y (2016) Diagnosis and treatment of lymphatic plastic bronchitis in adults using advanced lymphatic imaging and percutaneous embolization. Ann Am Thorac Soc 13:1689–1696PubMed
74.
Zurück zum Zitat Diab SG, Godang K, Muller LO et al (2019) Progressive loss of bone mass in children with Fontan circulation. Congenit Heart Dis 14:996–1004PubMedCrossRef Diab SG, Godang K, Muller LO et al (2019) Progressive loss of bone mass in children with Fontan circulation. Congenit Heart Dis 14:996–1004PubMedCrossRef
75.
Zurück zum Zitat Di Iorgi N, Maruca K, Patti G, Mora S (2018) Update on bone density measurements and their interpretation in children and adolescents. Best Pract Res Clin Endocrinol Metab 32:477–498PubMedCrossRef Di Iorgi N, Maruca K, Patti G, Mora S (2018) Update on bone density measurements and their interpretation in children and adolescents. Best Pract Res Clin Endocrinol Metab 32:477–498PubMedCrossRef
76.
Zurück zum Zitat Sun L, Macgowan CK, Sled JG et al (2015) Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease. Circulation 131:1313–1323PubMedPubMedCentralCrossRef Sun L, Macgowan CK, Sled JG et al (2015) Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease. Circulation 131:1313–1323PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Licht DJ, Shera DM, Clancy RR et al (2009) Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg 137:529–536PubMedPubMedCentralCrossRef Licht DJ, Shera DM, Clancy RR et al (2009) Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg 137:529–536PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Licht DJ, Wang J, Silvestre DW et al (2004) Preoperative cerebral blood flow is diminished in neonates with severe congenital heart defects. J Thorac Cardiovasc Surg 128:841–849PubMedCrossRef Licht DJ, Wang J, Silvestre DW et al (2004) Preoperative cerebral blood flow is diminished in neonates with severe congenital heart defects. J Thorac Cardiovasc Surg 128:841–849PubMedCrossRef
79.
Zurück zum Zitat Claessens NHP, Breur J, Groenendaal F et al (2019) Brain microstructural development in neonates with critical congenital heart disease: an atlas-based diffusion tensor imaging study. Neuroimage Clin 21:101672PubMedPubMedCentralCrossRef Claessens NHP, Breur J, Groenendaal F et al (2019) Brain microstructural development in neonates with critical congenital heart disease: an atlas-based diffusion tensor imaging study. Neuroimage Clin 21:101672PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Fogel MA, Li C, Elci OU et al (2017) Neurological injury and cerebral blood flow in single ventricles throughout staged surgical reconstruction. Circulation 135:671–682CrossRefPubMed Fogel MA, Li C, Elci OU et al (2017) Neurological injury and cerebral blood flow in single ventricles throughout staged surgical reconstruction. Circulation 135:671–682CrossRefPubMed
81.
Zurück zum Zitat Bellinger DC, Watson CG, Rivkin MJ et al (2015) Neuropsychological status and structural brain imaging in adolescents with single ventricle who underwent the Fontan procedure. J Am Heart Assoc 4:12CrossRef Bellinger DC, Watson CG, Rivkin MJ et al (2015) Neuropsychological status and structural brain imaging in adolescents with single ventricle who underwent the Fontan procedure. J Am Heart Assoc 4:12CrossRef
82.
Zurück zum Zitat Watson CG, Stopp C, Wypij D et al (2017) Reduced cortical volume and thickness and their relationship to medical and operative features in post-Fontan children and adolescents. Pediatr Res 81:881–890CrossRefPubMed Watson CG, Stopp C, Wypij D et al (2017) Reduced cortical volume and thickness and their relationship to medical and operative features in post-Fontan children and adolescents. Pediatr Res 81:881–890CrossRefPubMed
83.
Zurück zum Zitat Greenway SC, Crossland DS, Hudson M et al (2016) Fontan-associated liver disease: implications for heart transplantation. J Heart Lung Transplant 35:26–33CrossRefPubMed Greenway SC, Crossland DS, Hudson M et al (2016) Fontan-associated liver disease: implications for heart transplantation. J Heart Lung Transplant 35:26–33CrossRefPubMed
84.
Zurück zum Zitat Rossano JW, Dipchand AI, Edwards LB et al (2016) The registry of the International Society for Heart and Lung Transplantation: nineteenth pediatric heart transplantation report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant 35:1185–1195CrossRefPubMed Rossano JW, Dipchand AI, Edwards LB et al (2016) The registry of the International Society for Heart and Lung Transplantation: nineteenth pediatric heart transplantation report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant 35:1185–1195CrossRefPubMed
85.
Zurück zum Zitat Tabarsi N, Guan M, Simmonds J et al (2017) Meta-analysis of the effectiveness of heart transplantation in patients with a failing Fontan. Am J Cardiol 119:1269–1274CrossRefPubMed Tabarsi N, Guan M, Simmonds J et al (2017) Meta-analysis of the effectiveness of heart transplantation in patients with a failing Fontan. Am J Cardiol 119:1269–1274CrossRefPubMed
86.
Zurück zum Zitat Chang PT, Frost J, Stanescu AL et al (2016) Pediatric thoracic organ transplantation: current indications, techniques, and imaging findings. Radiol Clin N Am 54:321–338CrossRefPubMed Chang PT, Frost J, Stanescu AL et al (2016) Pediatric thoracic organ transplantation: current indications, techniques, and imaging findings. Radiol Clin N Am 54:321–338CrossRefPubMed
Metadaten
Titel
Imaging of complications following Fontan circulation in children — diagnosis and surveillance
verfasst von
Charlotte de Lange
Publikationsdatum
28.05.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 10/2020
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-020-04682-5

Weitere Artikel der Ausgabe 10/2020

Pediatric Radiology 10/2020 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.